- Home
- RVTY vs BAX Comparison
RVTY vs BAX Comparison
Compare RVTY & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVTY
- BAX
- Stock Information
- Founded
- RVTY 1937
- BAX 1931
- Country
- RVTY United States
- BAX United States
- Employees
- RVTY N/A
- BAX N/A
- Industry
- RVTY Biotechnology: Laboratory Analytical Instruments
- BAX Medical/Dental Instruments
- Sector
- RVTY Industrials
- BAX Health Care
- Exchange
- RVTY Nasdaq
- BAX Nasdaq
- Market Cap
- RVTY 11.4B
- BAX 12.4B
- IPO Year
- RVTY N/A
- BAX N/A
- Fundamental
- Price
- RVTY $82.88
- BAX $23.99
- Analyst Decision
- RVTY Buy
- BAX Hold
- Analyst Count
- RVTY 13
- BAX 9
- Target Price
- RVTY $120.08
- BAX $32.00
- AVG Volume (30 Days)
- RVTY 1.1M
- BAX 6.3M
- Earning Date
- RVTY 11-03-2025
- BAX 11-07-2025
- Dividend Yield
- RVTY 0.34%
- BAX 2.83%
- EPS Growth
- RVTY 72.56
- BAX N/A
- EPS
- RVTY 2.37
- BAX N/A
- Revenue
- RVTY $2,798,467,000.00
- BAX $10,887,000,000.00
- Revenue This Year
- RVTY $5.55
- BAX $7.38
- Revenue Next Year
- RVTY $4.40
- BAX $3.78
- P/E Ratio
- RVTY $35.00
- BAX N/A
- Revenue Growth
- RVTY 3.33
- BAX 3.60
- 52 Week Low
- RVTY $81.36
- BAX $21.33
- 52 Week High
- RVTY $129.50
- BAX $40.49
- Technical
- Relative Strength Index (RSI)
- RVTY 39.80
- BAX 44.82
- Support Level
- RVTY $82.47
- BAX $23.90
- Resistance Level
- RVTY $85.86
- BAX $24.63
- Average True Range (ATR)
- RVTY 2.69
- BAX 0.58
- MACD
- RVTY -0.38
- BAX 0.13
- Stochastic Oscillator
- RVTY 11.84
- BAX 54.06
About RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.